BiomX Inc.
PHGEAMEXHealthcare● Active
$0.76
+$0.04(+5.18%)
Market Cap$1206808
P/E Ratio—
52W High$14.706
52W Low$0.361
BiomX Inc. (PHGE) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PHGE · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 20, 2026EPS Actual
$0.03
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 20, 2026
After Market Close
🔥 5-Quarter EPS Beat Streak
PHGE reports quarterly as a AMEX-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | — | — | — | — | — | — |
| — Q2 FY2026 | May 20, 2026 | — | $0.03 | — | — | — | — |
| — Q1 FY2026 | Mar 24, 2026 | -$4.61 | -$4.61 | +0.0% | — | — | — |
| ▲ Q4 FY2025 | Nov 12, 2025 | -$6.08 | -$5.51 | +9.4% | — | — | — |
| ▲ Q3 FY2025 | Aug 13, 2025 | -$0.33 | $0.19 | +157.6% | — | — | — |
| ▲ Q2 FY2025 | May 15, 2025 | -$0.42 | -$0.33 | +21.4% | — | — | — |
| ▲ Q1 FY2025 | Mar 25, 2025 | -$1.65 | -$1.07 | +35.1% | — | — | — |
| ▼ Q4 FY2024 | Nov 14, 2024 | -$0.60 | -$0.97 | -61.7% | $-0.00B | — | — |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 20, 2026
EPS Actual
$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 24, 2026
EPS Actual
-$4.61
EPS Est.
-$4.61
EPS Surpr.
+0.0%
Revenue
—
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
-$5.51
EPS Est.
-$6.08
EPS Surpr.
+9.4%
Revenue
—
Q3 FY2025
Aug 13, 2025Beat
EPS Actual
$0.19
EPS Est.
-$0.33
EPS Surpr.
+157.6%
Revenue
—
Q2 FY2025
May 15, 2025Beat
EPS Actual
-$0.33
EPS Est.
-$0.42
EPS Surpr.
+21.4%
Revenue
—
Q1 FY2025
Mar 25, 2025Beat
EPS Actual
-$1.07
EPS Est.
-$1.65
EPS Surpr.
+35.1%
Revenue
—
Q4 FY2024
Nov 14, 2024Miss
EPS Actual
-$0.97
EPS Est.
-$0.60
EPS Surpr.
-61.7%
Revenue
$-0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2025 | $-5.06 | $-5.06 | $-5.06 | 1 |
| Q3 FY2025 | $-5.61 | $-5.61 | $-5.61 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 20, 2026 | — | $0.37 | $0.60 | +59.60% |
| ▲ Q1 FY2026 | Mar 24, 2026 | +0.0% | $4.64 | $4.86 | +4.74% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +9.4% | $7.29 | $7.15 | -1.92% |
| ▲ Q3 FY2025 | Aug 13, 2025 | +157.6% | $10.68 | $9.43 | -11.70% |
| ▲ Q2 FY2025 | May 15, 2025 | +21.4% | $10.39 | $10.71 | +3.08% |
| ▲ Q1 FY2025 | Mar 25, 2025 | +35.1% | $11.97 | $11.11 | -7.18% |
| ▼ Q4 FY2024 | Nov 14, 2024 | -61.7% | $13.75 | $14.25 | +3.64% |
| ▲ Q3 FY2024 | Aug 14, 2024 | +158.3% | $34.96 | $34.96 | +0.00% |
Q2 FY2026+59.60%
Report Date
May 20, 2026
EPS Beat/Miss
—
Price Before
$0.37
Price After
$0.60
Q1 FY2026+4.74%
Report Date
Mar 24, 2026
EPS Beat/Miss
+0.0%
Price Before
$4.64
Price After
$4.86
Q4 FY2025-1.92%
Report Date
Nov 12, 2025
EPS Beat/Miss
+9.4%
Price Before
$7.29
Price After
$7.15
Q3 FY2025-11.70%
Report Date
Aug 13, 2025
EPS Beat/Miss
+157.6%
Price Before
$10.68
Price After
$9.43
Q2 FY2025+3.08%
Report Date
May 15, 2025
EPS Beat/Miss
+21.4%
Price Before
$10.39
Price After
$10.71
Q1 FY2025-7.18%
Report Date
Mar 25, 2025
EPS Beat/Miss
+35.1%
Price Before
$11.97
Price After
$11.11
Q4 FY2024+3.64%
Report Date
Nov 14, 2024
EPS Beat/Miss
-61.7%
Price Before
$13.75
Price After
$14.25
Q3 FY2024+0.00%
Report Date
Aug 14, 2024
EPS Beat/Miss
+158.3%
Price Before
$34.96
Price After
$34.96
Avg Beat Reaction-2.16%
Avg Miss Reaction+3.64%
Beat Rate6 / 8 quarters
Largest Move+59.60% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PHGE ends December
BiomX Inc. (PHGE) most recently reported earnings on May 20, 2026 for Q2 FY2026, posting EPS of $0.03 (in line with the analyst consensus of —). PHGE has beaten EPS estimates for 5 consecutive quarters. The next PHGE earnings date is expected around September 1, 2026.
Each quarter, investors track PHGE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PHGE revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PHGE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PHGE earnings · 4 questionsBiomX Inc.'s next earnings report is expected around September 1, 2026. PHGE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PHGE historically reports after market close (AMC).
PHGE earnings datewhen is PHGE earningsPHGE next earnings datewhen does PHGE report earningsPHGE earnings calendar
▸ Source: FMP · BiomX Inc. SEC filings · US GAAP · BiomX Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026